FOXO Technologies Inc. Board of Directors

FOXO Technologies Inc. develops epigenetic biomarkers technology solutions in the United States. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers. FOXO Technologies Inc. was founded in 2020 and is based in Minneapolis, Minnesota.

Mr. Martin Christopher Ward FCA

Mr. Martin Christopher Ward FCA

Interim Chief Financial Officer

Mr. Mark Brian White

Mr. Mark Brian White

Interim CEO & Director

Mr. Jim Grauel Jr.

Mr. Jim Grauel Jr.

Chief Distribution Officer

Ms. Susan Neo

Ms. Susan Neo

Chief Security Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.